Home - Products - Others - Other Targets - Acacetin-7-O-3-Malonylglucoside

Acacetin-7-O-3-Malonylglucoside

CAS No. 1588563-85-2

Acacetin-7-O-3-Malonylglucoside( ——— )

Catalog No. M38392 CAS No. 1588563-85-2

Acacetin-7-O-(3-O-malonyl)-β-D-glucopyranoside (compound 13) is a compound that can be isolated from the moss Dicranum foetidum.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Acacetin-7-O-3-Malonylglucoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Acacetin-7-O-(3-O-malonyl)-β-D-glucopyranoside (compound 13) is a compound that can be isolated from the moss Dicranum foetidum.
  • Description
    Acacetin-7-O-(3-O-malonyl)-β-D-glucopyranoside (compound 13) is a compound that can be isolated from the moss Dicranum foetidum.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    1588563-85-2
  • Formula Weight
    532.45
  • Molecular Formula
    C25H24O13
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Selenge E, et al. Monoterpene glycosides, phenylpropanoids, and acacetin glycosides from Dracocephalum foetidumJ. Phytochemistry, 2014, 101: 91-100.
molnova catalog
related products
  • Adecatumumab

    Adecatumumab (MT201) is a whole-person IgG1 monoclonal antibody to human EpCAM. Adecatumumab has potential anticancer activity and can be used to study breast cancer.

  • Isonicotinamide

    Pharmaceutical intermediate used to synthesis Cefalonium, etc.

  • Astressin

    Astressin is an amino-terminal truncated analog of CRF that retains high affinity binding to the extracellular domain of the receptor and is believed to act as a neutral competitive antagonist of receptor activation.